112 results on '"Kornprat, Peter"'
Search Results
2. Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases—A Retrospective Analysis
3. Treatment characteristics and outcomes of pure Acinar cell carcinoma of the pancreas – A multicentric European study on radically resected patients
4. Gallstone as a cause of intestinal obstruction (Bouveret syndrome)
5. Sarcopenia Negatively Influences Translocations of Gut Microbiome into the Pancreas and Biliary Tract in Patients with Pancreatic Adenocarcinoma
6. Do Octogenarians Benefit From Pancreatic Resection For Pdac?
7. Incidence and risk factors for anastomotic bile leakage in hepatic resection with bilioenteric reconstruction – A international multicenter study
8. Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions
9. The Association of Microbiome in Pancreatic Cancer Patients and Postoperative Complication after Pancreatic Resection
10. Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases
11. Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastases
12. KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations
13. Sarcopenia and primary tumor location influence patients outcome after liver resection for colorectal liver metastases
14. Pankreasverletzungen
15. Platelet to Lymphocyte Ratio Correlates With Carcinoma Progression in Pancreatic Intra Epithelial Neoplasia
16. Is the new R0 resection the crucial corner stone within interdisciplinary therapy regimes to reach a prolonged OAS for PDAC patients
17. Neodadjuvant therapy influences sceletal muscle mass after liver resection for malignancies
18. Prevalence of sarcopenia in colorectal liver metastases varies according to primary tumor location
19. Low skeletal muscle mass is associated with high hospital costs in patients undergoind pancreatic cancer resection
20. Intraoperative radiation therapy in pancreatic cancer
21. The influence of gender on frailty syndrome in surgical patients undergoing major hepatic resections
22. Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence–Based Model
23. Sarcopenic Obesity in Patients Undergoing Pancreatic Ductal Adenocarcinoma Resection
24. Neoadjuvant Therapy Influences Skeletal Muscle Mass in Liver Resection
25. Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?
26. Laparoscopic cholecystectomy in critically ill patients
27. Performance of two prognostic scores that incorporate genetic information to predict long‐term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH‐MSK scores
28. Clinical Impact of Stump Closure Reinforced With Hemopatch on the Prevention of Clinically Relevant Pancreatic Fistula After Distal Pancreatectomy: A Multicenter Randomized Trial
29. The optimal cut‐off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi‐institutional study
30. A nomogram illustrating the probability of anastomotic leakage following cervical esophagogastrostomy
31. Low-Dose Intraoperative Radiation Does Positively Influence Recurrence after Resection of Retroperitoneal Liposarcoma
32. Quality Assessment in Surgical RCTs for Liver Resection Techniques: Have We Met the Standard Yet?
33. Sarcopenia Negatively Impacts Recurrence Rates of CRLM after Liver Resection
34. Biliary and Pancreatic Microbiome Influence the Postoperative Outcome after Whipple Procedure
35. The “critical view of safety (CVS)” cannot be applied—What to do? Strategies to avoid bile duct injuries
36. The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer
37. External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
38. A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study
39. Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients
40. Neodadjuvant Therapy Influences Sceletal Muscle Mass after Liver Resection for Malignancies
41. Sarcopenic Obesity Promotes Invasive Carcinomas in Patients with IPMN or PANin
42. Prevalence of Sarcopenia in Colorectal Liver Metastases Varies According to Primary Tumor Location
43. Sarcopenic Obesity Promotes Invasive Carcinomas in Patients with IPMN or PANin
44. Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT – A Pilot Study
45. Gastrointestinal complications following on-pump cardiac surgery—A propensity matched analysis
46. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer
47. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group
48. The Predictive Value of the CRP–to–Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study
49. Operative R0 resection of diffuse large B-cell lymphoma of the pelvis: a case report
50. Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.